{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:04:35Z","timestamp":1791975875036,"version":"4.4.0"},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study investigates the development and characterisation of niosome-based delivery systems for olanzapine, an antipsychotic drug. Niosomes were prepared using various grades of Span surfactants (Span 60, Span 40, and Span 20) in combination with cholesterol at different ratios. The formulations were characterised in terms of particle size, polydispersity index, zeta potential, and encapsulation efficiency. Results showed an inverse relationship between surfactant hydrophilic-lipophilic balance (HLB) values and niosome size, with Span 60 producing the smallest vesicles. Optimal formulations were achieved with a 1:1 ratio of surfactant to cholesterol. Span 60 niosomes exhibited the highest encapsulation efficiency (up to 81 \u00b1 2.5 %) and the most negative zeta potential, indicating superior stability.\n                    <jats:italic>In vitro<\/jats:italic>\n                    release studies demonstrated sustained release profiles for all niosomal formulations compared to the free drug, with Span 60 formulations showing the slowest release rates. Release kinetics analysis revealed a Fickian diffusion-controlled mechanism best described by the Korsmeyer-Peppas model. These findings suggest that niosomal formulations, particularly those based on Span 60, offer a promising approach for improving olanzapine delivery, potentially enhancing its bioavailability and therapeutic efficacy in the treatment of psychiatric disorders.\n                  <\/jats:p>","DOI":"10.2478\/acph-2025-0026","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T14:59:44Z","timestamp":1756479584000},"page":"531-545","source":"Crossref","is-referenced-by-count":2,"title":["Niosome-based delivery systems for olanzapine: Formulation, characterisation, and kinetic evaluation"],"prefix":"10.2478","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8077-9103","authenticated-orcid":false,"given":"Samiah","family":"Alhabardi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics College of Pharmacy , King Saud University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-2510","authenticated-orcid":false,"given":"Basmah","family":"Aldosari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics College of Pharmacy , King Saud University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5313-7153","authenticated-orcid":false,"given":"Gadah","family":"Al-Hamoud","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy College of Pharmacy , King Saud University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shog Moahmmed","family":"Alali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics College of Pharmacy , King Saud University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema Al","family":"Khbiah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics College of Pharmacy , King Saud University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Albulayhi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics College of Pharmacy , King Saud University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-9464","authenticated-orcid":false,"given":"Wedad","family":"Sarawi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology , College of Pharmacy King Saud University , P.O. Box 22452, Riyadh 11495 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7804-5626","authenticated-orcid":false,"given":"Naifa","family":"Alenazi","sequence":"additional","affiliation":[{"name":"College of Pharmacy , Princess Nourah bint Abdulrahman University , Riyadh , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"2026051108182294429_j_acph-2025-0026_ref_001","doi-asserted-by":"crossref","unstructured":"J. Paik, Olanzapine\/Samidorphan: First approval, Drugs 81 (2021) 1431\u20131436; https:\/\/doi.org\/10.1007\/s40265-021-01568-0","DOI":"10.1007\/s40265-021-01568-0"},{"key":"2026051108182294429_j_acph-2025-0026_ref_002","doi-asserted-by":"crossref","unstructured":"P. Zubiaur, P. Soria-Chacartegui, G. Villapalos-Garc\u00eda, J. J. Gordillo-Perdomo and F. Abad-Santos, The pharmacogenetics of treatment with olanzapine, Pharmacogenomics 22(14) (2021) 939\u2013958; https:\/\/doi.org\/10.2217\/pgs-2021-0051","DOI":"10.2217\/pgs-2021-0051"},{"key":"2026051108182294429_j_acph-2025-0026_ref_003","doi-asserted-by":"crossref","unstructured":"M. Jovanovi\u0107, K. Vu\u010di\u0107evi\u0107 and B. Miljkovi\u0107, Understanding variability in the pharmacokinetics of atypical antipsychotics \u2013 focus on clozapine, olanzapine and aripiprazole population models, Drug Metab. Rev. 52(1) (2020) 1\u201318; https:\/\/doi.org\/10.1080\/03602532.2020.1717517","DOI":"10.1080\/03602532.2020.1717517"},{"key":"2026051108182294429_j_acph-2025-0026_ref_004","unstructured":"V. Krishnamoorthy, A. Nagalingam, V. P. Ranjan Prasad, S. Parameshwaran, N. George and P. Kaliyan, Characterization of olanzapine-solid dispersions, Iran. J. Pharm. Res. 10(1) (2011) 13\u201324; https:\/\/doi.org\/10.22037\/IJPR.2010.880"},{"key":"2026051108182294429_j_acph-2025-0026_ref_005","doi-asserted-by":"crossref","unstructured":"J. H. Mao, L. Han, X. Q. Liu and Z. Jiao, Significant predictors for olanzapine pharmacokinetics: A systematic review of population pharmacokinetic studies, Expert Rev. Clin. Pharmacol. 16(6) (2023) 575\u2013588; https:\/\/doi.org\/10.1080\/17512433.2023.2219055","DOI":"10.1080\/17512433.2023.2219055"},{"key":"2026051108182294429_j_acph-2025-0026_ref_006","unstructured":"M. Ur Rehman, A. Rasul, M. I. Khan, M. Rasool, G. Abbas, F. Masood, I. Nazir, M. Iqbal, N. Islam, M. Hameed and P. Akhtar Shah, Oral bioavailability studies of niosomal formulations of cyclosporine A in albino rabbits, Pak. J. Pharm. Sci. 34(1) (2021) 313\u2013319."},{"key":"2026051108182294429_j_acph-2025-0026_ref_007","unstructured":"A. Shahiwala and A. Misra, Studies in topical application of niosomally entrapped nimesulide, J. Pharm. Pharm. Sci. 5(3) (2002) 220\u2013225; https:\/\/pubmed.ncbi.nlm.nih.gov\/12553889"},{"key":"2026051108182294429_j_acph-2025-0026_ref_008","doi-asserted-by":"crossref","unstructured":"P. L. Yeo, C. L. Lim, S. M. Chye, A. P. K. Ling and R. Y. Koh, Niosomes: A review of their structure, properties, methods of preparation, and medical applications, Asian Biomed. 11(4) (2018) 301\u2013314; https:\/\/doi.org\/10.1515\/abm-2018-0002","DOI":"10.1515\/abm-2018-0002"},{"key":"2026051108182294429_j_acph-2025-0026_ref_009","doi-asserted-by":"crossref","unstructured":"Y. K. Lin, C. Y. Hsiao, A. Alshetaili, I. A. Aljuffali, E. L. Chen and J. Y. Fang, Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim, Eur. J. Pharm. Sci. 186 (2023) Article ID 106458 (13 pages); https:\/\/doi.org\/10.1016\/j.ejps.2023.106458","DOI":"10.1016\/j.ejps.2023.106458"},{"key":"2026051108182294429_j_acph-2025-0026_ref_010","doi-asserted-by":"crossref","unstructured":"M. Moghtaderi, K. Sedaghatnia, M. Bourbour, M. Fatemizadeh, Z. S. M. Moghaddam, F. Hejabi, F. Heidari, S. Quazi and B. Farasati Far, Niosomes: A novel targeted drug delivery system for cancer, Med. Oncol. 39 (2022) Article ID 240; https:\/\/doi.org\/10.1007\/s12032-022-01836-3","DOI":"10.1007\/s12032-022-01836-3"},{"key":"2026051108182294429_j_acph-2025-0026_ref_011","doi-asserted-by":"crossref","unstructured":"D. A. Deulkar, J. A. Kubde, P. R. Hatwar, R. L. Bakal and A. N. Motwani, Niosomes: A promising approach for targeted drug delivery, GSC Biol. Pharm. Sci. 29(1) (2024) 179\u2013195; https:\/\/doi.org\/10.30574\/gscbps.2024.29.1.0341","DOI":"10.30574\/gscbps.2024.29.1.0341"},{"key":"2026051108182294429_j_acph-2025-0026_ref_012","doi-asserted-by":"crossref","unstructured":"S. Gao, Z. Sui, Q. Jiang and Y. Jiang, Functional evaluation of niosomes utilizing surfactants in nanomedicine applications, Int. J. Nanomedicine 2024 (2024) 10283\u201310305; https:\/\/doi.org\/10.2147\/IJN.S480639","DOI":"10.2147\/IJN.S480639"},{"key":"2026051108182294429_j_acph-2025-0026_ref_013","doi-asserted-by":"crossref","unstructured":"M. Yaghoobian, A. Haeri, N. Bolourchian, S. Shahhosseni and S. Dadashzadeh, The impact of surfactant composition and surface charge of niosomes on the oral absorption of repaglinide as a BCS II model drug, Int. J. Nanomedicine 2020 (2020) 8767\u20138781; https:\/\/doi.org\/10.2147\/IJN.S261932","DOI":"10.2147\/IJN.S261932"},{"key":"2026051108182294429_j_acph-2025-0026_ref_014","doi-asserted-by":"crossref","unstructured":"B. D. Coday, T. Luxbacher, A. E. Childress, N. Almaraz, P. Xu and T. Y. Cath, Indirect determination of zeta potential at high ionic strength: Specific application to semipermeable polymeric membranes, J. Memb. Sci. 478 (2015) 58\u201364; https:\/\/doi.org\/10.1016\/j.memsci.2014.12.047","DOI":"10.1016\/j.memsci.2014.12.047"},{"key":"2026051108182294429_j_acph-2025-0026_ref_015","doi-asserted-by":"crossref","unstructured":"A. K. Sailaja and M. Shreya, Preparation and characterization of naproxen loaded niosomes by ether injection method, Nano Biomed. Eng. 10(2) (2018) 143\u2013149; https:\/\/doi.org\/10.5101\/nbe.v10i2.p174-180","DOI":"10.5101\/nbe.v10i2.p174-180"},{"key":"2026051108182294429_j_acph-2025-0026_ref_016","doi-asserted-by":"crossref","unstructured":"A. Moammeri, M. M. Chegeni, H. Sahrayi, R. Ghafelehbashi, F. Memarzadeh, A. Mansouri, I. Akbarzadeh, M. Sadat Abtahi, F. Hejabi and Q. Ren, Current advances in niosomes applications for drug delivery and cancer treatment, Mater. Today Bio. 23 (2023) Article ID 100837 (20 pages); https:\/\/doi.org\/10.1016\/j.mtbio.2023.100837","DOI":"10.1016\/j.mtbio.2023.100837"},{"key":"2026051108182294429_j_acph-2025-0026_ref_017","doi-asserted-by":"crossref","unstructured":"P. Pandey, R. Pal, V. K. R. Khadam, H. S. Chawra and R. P. Singh, Advancement and characteristics of non-ionic surfactant vesicles (niosome) and their application for analgesics, Int. J. Pharm. Investig. 14(3) (2024) 616\u2013632; https:\/\/doi.org\/10.5530\/IJPI.14.3.74","DOI":"10.5530\/ijpi.14.3.74"},{"key":"2026051108182294429_j_acph-2025-0026_ref_018","doi-asserted-by":"crossref","unstructured":"D. Pozzi, R. Caminiti, C. Marianecci, M. Carafa, E. Santucci, S. C. De Sanctis and G. Caracciolo, Effect of cholesterol on the formation and hydration behavior of solid-supported niosomal membranes, Langmuir 26(4) (2010) 2268\u20132273; https:\/\/doi.org\/10.1021\/la9026877","DOI":"10.1021\/la9026877"},{"key":"2026051108182294429_j_acph-2025-0026_ref_019","doi-asserted-by":"crossref","unstructured":"M. H. Nematollahi, A. Pardakhty, M. Torkzadeh-Mahanai, M. Mehrabani and G. Asadikaram, Changes in physical and chemical properties of niosome membrane induced by cholesterol: A promising approach for niosome bilayer intervention, RSC Adv. 7 (2017) Article ID 49463 (10 pages); https:\/\/doi.org\/10.1039\/C7RA07834J","DOI":"10.1039\/C7RA07834J"},{"key":"2026051108182294429_j_acph-2025-0026_ref_020","doi-asserted-by":"crossref","unstructured":"F. Nowroozi, A. Almasi, J. Javidi, A. Haeri and S. Dadashzadeh, Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes, Iran. J. Pharm. Res. 17 (2018) 1\u201313.","DOI":"10.2217\/nnm-2018-0091"},{"key":"2026051108182294429_j_acph-2025-0026_ref_021","doi-asserted-by":"crossref","unstructured":"P. Palozza, R. Muzzalupo, S. Trombino, A. Valdannini and N. Picci, Solubilization and stabilization of \u03b2-carotene in niosomes: Delivery to cultured cells, Chem. Phys. Lipids 139(1) (2006) 32\u201342; https:\/\/doi.org\/10.1016\/j.chemphyslip.2005.09.004","DOI":"10.1016\/j.chemphyslip.2005.09.004"},{"key":"2026051108182294429_j_acph-2025-0026_ref_022","doi-asserted-by":"crossref","unstructured":"A. Manosroi, P. Wongtrakul, J. Manosroi, H. Sakai, F. Sugawara, M. Yuasa and M. Abe, Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol, Colloids Surf. B Biointerfaces 30(1\u20132) (2003) 129\u2013138; https:\/\/doi.org\/10.1016\/S0927-7765(03)00080-8","DOI":"10.1016\/S0927-7765(03)00080-8"},{"key":"2026051108182294429_j_acph-2025-0026_ref_023","doi-asserted-by":"crossref","unstructured":"N. Ruwizhi and B. A. Aderibigbe, The efficacy of cholesterol-based carriers in drug delivery, Molecules 25(18) (2020) Article ID 4330 (40 pages); https:\/\/doi.org\/10.3390\/molecules25184330","DOI":"10.3390\/molecules25184330"},{"key":"2026051108182294429_j_acph-2025-0026_ref_024","doi-asserted-by":"crossref","unstructured":"N. S. Heredia, K. Vizuete, M. Flores-Calero, V. Pazmi\u00f1o, F. K. Pilaquinga, B. Kumar and A. Debut, Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid), PLoS One 17 (2022) e0264825 (18 pages); https:\/\/doi.org\/10.1371\/journal.pone.0264825","DOI":"10.1371\/journal.pone.0264825"},{"key":"2026051108182294429_j_acph-2025-0026_ref_025","doi-asserted-by":"crossref","unstructured":"I. Y. Wu, S. Bala, N. \u0160kalko-Basnet and M. P. di Cagno, Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes, Eur. J. Pharm. Sci. 138 (2019) Article ID 105026 (14 pages); https:\/\/doi.org\/10.1016\/j.ejps.2019.105026","DOI":"10.1016\/j.ejps.2019.105026"},{"key":"2026051108182294429_j_acph-2025-0026_ref_026","doi-asserted-by":"crossref","unstructured":"S. Zolghadri, A. G. Asad, F. Farzi, F. Ghajarzadeh, Z. Habibi, M. Rahban, S. Zolghadri and A. Stanek, Span 60\/cholesterol niosomal formulation as a suitable vehicle for gallic acid delivery with potent in vitro antibacterial, antimelanoma, and antityrosinase activity, Pharmaceuticals 16(12) (2023) Article ID 1680; https:\/\/doi.org\/10.3390\/ph16121680","DOI":"10.3390\/ph16121680"},{"key":"2026051108182294429_j_acph-2025-0026_ref_027","doi-asserted-by":"crossref","unstructured":"B. Korchowiec, M. Paluch, Y. Corvis and E. Rogalska, A Langmuir film approach to elucidating interactions in lipid membranes: 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine\/cholesterol\/metal cation systems, Chem. Phys. Lipids 144(2) (2006) 127\u2013136; https:\/\/doi.org\/10.1016\/j.chemphyslip.2006.08.005","DOI":"10.1016\/j.chemphyslip.2006.08.005"},{"key":"2026051108182294429_j_acph-2025-0026_ref_028","doi-asserted-by":"crossref","unstructured":"A. Rasul, M. Imran Khan, M. U. Rehman, G. Abbas, N. Aslam, S. Ahmad, K. Abbas, P. Akhtar Shah, M. Iqbal,A. M. Ahmed Al Subari, T. Shaheer and S. Shas, In vitro characterization and release studies of combined nonionic surfactant-based vesicles for the prolonged delivery of an immunosuppressant model drug, Int. J. Nanomedicine 2020 (2020) 7937\u20137949; https:\/\/doi.org\/10.2147\/IJN.S268846","DOI":"10.2147\/IJN.S268846"},{"key":"2026051108182294429_j_acph-2025-0026_ref_029","doi-asserted-by":"crossref","unstructured":"M. H. Mowlaeifar, M. Niakousari, S. M. H. Hosseini and M. H. Eskandari, Effect of cholesterol to vitamin D3 and Span 60 to Tween 60 ratios on the characteristics of niosomes: Variable optimization using response surface methodology (RSM), J. Food Qual. 2022 (2022) Article ID 7005531 (8 pages); https:\/\/doi.org\/10.1155\/2022\/7005531","DOI":"10.1155\/2022\/7005531"},{"key":"2026051108182294429_j_acph-2025-0026_ref_030","doi-asserted-by":"crossref","unstructured":"G. Abdelbary and N. El-gendy, Niosome-encapsulated gentamicin for ophthalmic controlled delivery, AAPS PharmSciTech 9 (2008) 740\u2013747; https:\/\/doi.org\/10.1208\/s12249-008-9105-1","DOI":"10.1208\/s12249-008-9105-1"},{"key":"2026051108182294429_j_acph-2025-0026_ref_031","doi-asserted-by":"crossref","unstructured":"P. Balakrishnan, B. J. Lee, D. H. Oh, J. O. Kim, Y. I. Lee, D. D. Kim, J.-P. Jee, Y.-B. Lee, J. S. Woo, C. S. Yong and H.-G. Choi, Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems, Int. J. Pharm. 374(1\u20132) (2009) 66\u201372; https:\/\/doi.org\/10.1016\/j.ijpharm.2009.03.008","DOI":"10.1016\/j.ijpharm.2009.03.008"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2025-0026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:26:20Z","timestamp":1778487980000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2025-0026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,10,10]]},"published-print":{"date-parts":[[2025,9,1]]}},"alternative-id":["10.2478\/acph-2025-0026"],"URL":"https:\/\/doi.org\/10.2478\/acph-2025-0026","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}